Retrospective analysis of primary gastric diffuse large B cell lymphoma in the rituximab era: A multicenter study of 95 patients in Japan

Annals of Hematology

Volumn 91, Issue 3, 2012, Pages 383-390

  Tanaka, Tsutomu ^a,b   Shimada, Kazuyuki ^a   Yamamoto, Kazuhito ^c   Hirooka, Yoshiki ^a   Niwa, Yasumasa ^c   Sugiura, Isamu ^d   Kitamura, Kunio ^e   Kosugi, Hiroshi ^f   Kinoshita, Tomohiro ^a   Goto, Hidemi ^a   Nakamura, Shigeo ^b  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NAGOYA UNIVERSITY HOSPITAL   (Japan)

^c AICHI CANCER CENTER HOSPITAL   (Japan)

^d TOYOHASHI MUNICIPAL HOSPITAL   (Japan)

^e Ichinomiya Municipal Hospital   (Japan)

^f OGAKI MUNICIPAL HOSPITAL   (Japan)

Author keywords

Diffuse large B cell lymphoma; Primary gastric lymphoma; Radiotherapy; Relapse; Rituximab

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; LACTATE DEHYDROGENASE; PREDNISOLONE; RITUXIMAB; VINCRISTINE;

ADULT; ADVANCED CANCER; AGE; AGED; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; BONE MARROW; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RELAPSE; CENTRAL NERVOUS SYSTEM; CERVICAL LYMPH NODE; CHEMORADIOTHERAPY; DUODENUM; ERADICATION THERAPY; FEMALE; GERMINAL CENTER; HELICOBACTER PYLORI; HUMAN; JAPAN; LACTATE DEHYDROGENASE BLOOD LEVEL; LARGE CELL LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM LYMPH NODE; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; MULTICENTER STUDY (TOPIC); MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; PARAAORTIC LYMPH NODE; PHENOTYPE; PRIMARY GASTRIC DIFFUSE LARGE B CELL LYMPHOMA; PRIMARY TUMOR; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RETROSPECTIVE STUDY; SEX DIFFERENCE; STOMACH HEMORRHAGE; STOMACH LYMPHOMA; STOMACH OBSTRUCTION; STOMACH PERFORATION; TREATMENT RESPONSE; TUMOR LOCALIZATION;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CYCLOPHOSPHAMIDE; DISEASE-FREE SURVIVAL; DOXORUBICIN; FEMALE; HUMANS; JAPAN; LYMPHOMA, LARGE B-CELL, DIFFUSE; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; PREDNISONE; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS; TREATMENT OUTCOME; VINCRISTINE;

EID: 84857370391     PISSN: 09395555     EISSN: 14320584     Source Type: Journal    
DOI: 10.1007/s00277-011-1306-0     Document Type: Article

References (20)

1. Koch P, del Valle F, Berdel WE, et al. German Multicenter Study Group. Primary gastrointestinal non-Hodgkin's lymphoma: II. Combined surgical and conservative or conservative management only in localized gastric lymphoma-results of the prospective German Multicenter Study GIT NHL 01/92. J Clin Oncol. 2001;19:3874-83. (Pubitemid 32880066)
2. F Brands SP Monig M Raab 1997 Treatment and prognosis of gastric lymphoma Eur J Surg 163 803 813 9414040 1:STN:280:DyaK1c%2FnsVymsw%3D%3D Review (Pubitemid 27485955)
3. A Aviles MJ Nambo N Neri, et al. 2004 The role of surgery in primary gastric lymphoma: results of a controlled clinical trial Ann Surg 240 44 50 15213617 10.1097/01.sla.0000129354.31318.f1 (Pubitemid 38808233)
4. S Ishikura K Tobinai A Ohtsu, et al. 2005 Japanese multicenter phase II study of CHOP followed by radiotherapy in stage I-II, diffuse large B-cell lymphoma of the stomach Cancer Sci 96 349 352 15958057 10.1111/j.1349-7006.2005. 00051.x 1:CAS:528:DC%2BD2MXmsVGqsL8%3D (Pubitemid 41007469)
5. G Martinelli F Gigli L Calabrese, et al. 2009 Early stage gastric diffuse large B-cell lymphomas: results of a randomised trial comparing chemotherapy alone versus chemotherapy + involved field radiotherapy. (IELSG 4) Leuk Lymphoma 50 925 931 19479614 10.1080/10428190902912478 1:CAS:528:DC%2BD1MXntFChtr8%3D
6. G Salles R Herbrecht H Tilly, et al. 1991 Aggressive primary gastrointestinal lymphomas: review of 91 patients treated with the LNH-84 regimen. A study of the Groupe d'Etude des Lymphomes Agressifs Am J Med 90 77 84 1702581 10.1016/0002-9343(91)90509-V 1:STN:280:DyaK3M%2Fps1ygtw%3D%3D
7. B Coiffier G Salles 1997 Does surgery belong to medical history for gastric lymphomas? Ann Oncol 8 419 421 9233518 10.1023/A:1008254617270 1:STN:280:DyaK2sznsl2iug%3D%3D (Pubitemid 27310683)
8. B Coiffier E Lepage J Briere, et al. 2002 CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma N Engl J Med 346 235 242 11807147 10.1056/NEJMoa011795 1:CAS:528:DC%2BD38XmslGgsw%3D%3D (Pubitemid 34438862)
9. M Pfreundschuh L Trümper A Osterborg MabThera International Trial Group, et al. 2006 CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group Lancet Oncol 7 379 391 16648042 10.1016/S1470-2045(06)70664-7 1:CAS:528:DC%2BD28XjvFWlsbw%3D
10. S Wöhrer A Püspök J Drach, et al. 2004 Rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone (R-CHOP) for treatment of early-stage gastric diffuse large B-cell lymphoma Ann Oncol 15 1086 1090 15205203 10.1093/annonc/mdh261 (Pubitemid 39089786)
11. A Avilés C Castañeda S Cleto, et al. 2009 Rituximab and chemotherapy in primary gastric lymphoma Cancer Biother Radiopharm 24 25 28 19216628 10.1089/cbr.2008.0507
12. KJ Lewin M Ranchod RF Dorfman 1978 Lymphomas of the gastrointestinal tract: a study of 117 cases presenting with gastrointestinal disease Cancer 42 693 707 354774 10.1002/1097-0142(197808)42:2<693::AID-CNCR2820420241>3.0. CO;2-J 1:STN:280:DyaE1c3js12lsA%3D%3D (Pubitemid 8405865)
13. A Rohatiner F d'Amore B Coiffier, et al. 1994 Report on a workshop convened to discuss the pathological and staging classifications of gastrointestinal tract lymphoma Ann Oncol 5 397 400 8075046 1:STN:280: DyaK2czlsFamtQ%3D%3D (Pubitemid 24159642)
14. LH Sehn B Berry M Chhanabhai, et al. 2007 The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP Blood 109 1857 1861 17105812 10.1182/blood-2006-08-038257 1:CAS:528:DC%2BD2sXjtFeqt7g%3D (Pubitemid 46348180)
15. Swerdlow SH, Campo E, Harris NL et al (2008) WHO classification of tumours of haematopoietic and lymphoid tissues, 4th edn. International Agency for Research on Cancer, Lyon
16. CP Hans DD Weisenburger TC Greiner, et al. 2004 Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray Blood 103 275 282 14504078 10.1182/blood-2003-05-1545 1:CAS:528:DC%2BD2cXhsFGhsA%3D%3D (Pubitemid 38029949)
17. SH Bernstein JM Unger M Leblanc J Friedberg TP Miller RI Fisher 2009 Natural history of CNS relapse in patients with aggressive non-Hodgkin's lymphoma: a 20-year follow-up analysis of SWOG 8516-the Southwest Oncology Group J Clin Oncol 27 114 119 19047289 10.1200/JCO.2008.16.8021
18. J Huang W Jiang R Xu, et al. 2010 Primary gastric non-Hodgkin's lymphoma in Chinese patients: clinical characteristics and prognostic factors BMC Cancer 10 358 20604963 10.1186/1471-2407-10-358
19. G Spectre D Libster S Grisariu, et al. 2006 Bleeding, obstruction, and perforation in a series of patients with aggressive gastric lymphoma treated with primary chemotherapy Ann Surg Oncol 13 1372 1378 17009162 10.1245/s10434-006-9069-x
20. DO Persky JM Unger CM Spier, et al. 2008 Phase II study of rituximab plus three cycles of CHOP and involved-field radiotherapy for patients with limited-stage aggressive B-cell lymphoma: Southwest Oncology Group Study 0014 J Clin Oncol 26 2258 2263 18413640 10.1200/JCO.2007.13.6929 1:CAS:528: DC%2BD1cXntVOltrw%3D